SXT1596 是一种新型抑制剂,能够阻断 SS18-SSX/TLE1 交互作用。研究显示,SXT1596 可以降低细胞活力,并重新激活 EGR1 表达,在治疗滑膜肉瘤方面表现出潜力。
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
异黄樟素 | isosafrole | 120-58-1 | C10H10O2 | 162.188 |
胡椒醛 | piperonal | 120-57-0 | C8H6O3 | 150.134 |
3,4-亚甲二氧基苄胺 | 1,3-benzodioxol-5-ylmethyl amine | 2620-50-0 | C8H9NO2 | 151.165 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | 5-nitro-6-(2-nitro-propenyl)-benzo[1,3]dioxole | 88484-87-1 | C10H8N2O6 | 252.183 |
A derivative series of 3,4-dimethoxy-β-nitrostyrene was synthesized through nitroaldol reaction, including a new compound of 3,4-ethylenedioxy-β-bromo-β-nitrostyrene. The antimicrobial activity effect of 3,4-alkyloxy modification of β-nitrostyrene was investigated. A molecular docking study was also performed to obtain information about their interactions with protein tyrosine phosphatase 1B (PTP1B). The active residues of cysteine-215 and arginine-221 of PTP1B play a key role in signaling pathways that regulate various microorganism cell functions. It also acts as a negative regulator in signaling pathways of insulin that are involved in type 2 diabetes and other metabolic diseases. These derivatives exhibited potential antifungal activity. The studied compounds were also had potential as fragments to be PTP1B inhibitors by interacting with serine-216 and arginine-221 residues, according to their molecular docking. 3,4-Ethylenedioxy-β-methyl-β-nitrostyrene was the most successful potential candidate as a PTP1B inhibitor. However, further research is needed to investigate their potential for medicinal use.